摘要
<正>随着肝移植技术的进步以及新型免疫抑制剂的使用,肝移植受者生存率及生存质量已有明显提升,但免疫抑制剂的长期应用也增加了肝移植术后上消化道并发症甚至新发恶性肿瘤的风险。Herrero等[1]的研究发现,在肝移植受者人群中,胃肠道并发症的患病率约为50%,此类并发症对肝移植受者生存质量及存活时间影响较大,国内的肝移植中心也有关于肝移植受者新发消化系统肿瘤导致预后较差的报道[2],因此,本文将从肝移植受者常见上消化道疾病发生率及影响因素方面进行综述。1肝移植术后反流性食管炎
引文
[1]Herrero JI,Benlloch S,Bernardos A,et al.Gastrointestinal complications in liver transplant recipients:MITOS study[J].Transplant Proc,2007,39(7):2311-2313.
[2]牛斌,易述红,许赤,等.肝移植术后新发消化系统恶性肿瘤四例临床分析并文献复习[J/CD].中华肝脏外科手术学电子杂志,2013,2(3):167-170.
[3]Karasu Z,Hulagu S,Gurakar A,et al.High incidence of noninfectious esophagitis in orthotopic liver transplant(OLT)recipients[J].J Okla State Med Assoc,2001,94(2):43-45.
[4]Kim IS,Lee H,Park JC,et al.Increased incidence of endoscopic erosive esophagitis in solid organ transplant recipients[J].Gut Liver,2012,6(3):349-354.
[5]Akatsu T,Yoshida M,Kawachi S,et al.Consequences of livingdonor liver transplantation for upper gastrointestinal lesions:high incidence of reflux esophagitis[J].Dig Dis Sci,2006,51(11):2018-2022.
[6]Helderman JH,Goral S.Gastrointestinal complications of transplant immunosuppression[J].J Am Soc Nephrol,2002,13(1):277-287.
[7]Takeshita E,Sakata Y,Hara M,et al.Higher frequency of reflux symptoms and acid-related dyspepsia in women than men regardless of endoscopic esophagitis:analysis of 3 505 japanese subjects undergoing medical health checkups[J].Digestion,2016,93(4):266-271.
[8]Lee SP,Sung IK,Kim JH,et al.The effect of emotional stress and depression on the prevalence of digestive diseases[J].J Neurogastroenterol Motil,2015,21(2):273-282.
[9]Camilleri M,Malhi H,Acosta A.Gastrointestinal complications of obesity[J].Gastroenterology,2017,152(7):1656-1670.
[10]Hosotani Y,Kawanami C,Hasegawa K,et al.A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation[J].Transplantation,2003,76(4):702-704.
[11]Ma Y,He XS,Zhu XF,et al.Etiology and management of postoperative gastrointestinal bleeding after orthotopic liver transplantation[J].Zhonghua Wei Chang Wai Ke Za Zhi,2010,13(1):26-28.
[12]Sheiner PA,Magliocca JF,Bodian CA,et al.Long-term medical complications in patients surviving>or=5 years after liver transplant[J].Transplantation,2000,69(5):781-789.
[13]Telkes G,Peter A,Tulassay Z,et al.High frequency of ulcers,not associated with Helicobacter pylori,in the stomach in the first year after kidney transplantation[J].Nephrol Dial Transplant,2011,26(2):727-732.
[14]Guilbeau JM.Delayed wound healing with sirolimus after liver transplant[J].Ann Pharmacother,2002,36(9):1391-1395.
[15]Smith AD,Bai D,Marroquin CE,et al.Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus[J].Clin Transplant,2005,19(2):250-254.
[16]Jones MP.The role of psychosocial factors in peptic ulcer disease:beyond Helicobacter pylori and NSAIDs[J].J Psychosom Res,2006,60(4):407-412.
[17]Chetaikina AV,Skliarova O.[Influence of smoking on the effectiveness of peptic ulcer healing[J].Wiad Lek,2014,67(2 Pt 2):273-275.
[18]Schrem H,Kurok M,Kaltenborn A,et al.Incidence and longterm risk of de novo malignancies after liver transplantation with implications for prevention and detection[J].Liver Transpl,2013,19(11):1252-1261.
[19]Sanaei AK,Aliakbarian M,Kazemi K,et al.De novo malignancy after liver transplant[J].Exp Clin Transplant,2015,13(2):163-166.
[20]张彤,傅斌生,李华,等.肝移植术后新发胃癌1例临床分析附文献复习[J].器官移植,2011,(2):82-85.
[21]王振,李世朋,张建军.肝移植术后新发消化系统恶性肿瘤8例临床分析[J/CD].实用器官移植电子杂志,2016,4(1):37-39.
[22]张志军,钟海钢,张微,等.肝移植术后新发消化系统恶性肿瘤的诊治十例[J].中华器官移植杂志,2016,37(9):513-517.
[23]Grulich AE,van Leeuwen MT,Falster MO,et al.Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients:a meta-analysis[J].Lancet,2007,370(9581):59-67.
[24]Zamoiski RD,Yanik E,Gibson TM,et al.Risk of second malignancies in solid organ transplant recipients who develop keratinocyte cancers[J].Cancer Res,2017,77(15):4196-4203.
[25]Singla M,Kumar A,Bal A,et al.Epithelial to mesenchymal transition induces stem cell like phenotype in renal cell carcinoma cells[J].Cancer Cell Int,2018,18:57.
[26]Maluccio M,Sharma V,Lagman M,et al.Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression[J].Transplantation,2003,76(3):597-602.
[27]Caillard S,Dharnidharka V,Agodoa L,et al.Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression[J].Transplantation,2005,80(9):1233-1243.
[28]Wang H,Wang Y.LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine[J].Anal Chem,2010,82(13):5797-5803.
[29]Luo B,Wang Y,Wang XF,et al.Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas[J].World JGastroenterol,2005,11(5):629-633.
[30]Ribeiro J,Oliveira C,Malta M,et al.Epstein-Barr virus gene expression and latency pattern in gastric carcinomas:a systematic review[J].Future Oncol,2017,13(6):567-579.
[31]Morales-Sanchez A,Fuentes-Panana EM.Epstein-Barr Virus-associated gastric cancer and potential mechanisms of oncogenesis[J].Curr Cancer Drug Targets,2017,17(6):534-554.
[32]Cárdenas-Mondragón MG,Torres J,Sánchez-Zauco N,et al.Elevated levels of interferon-gamma are associated with high levels of Epstein-Barr Virus reactivation in patients with the intestinal type of gastric cancer[J].J Immunol Res,2017,2017:7069242.
[33]Shin CM,Kim N,Jung Y,et al.Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis[J].Cancer Sci,2010,101(6):1337-1346.
[34]Herrero JI,Lorenzo M,Quiroga J,et al.De Novo neoplasia after liver transplantation:an analysis of risk factors and influence on survival[J].Liver Transpl,2005,11(1):89-97.
[35]van der Heide F,Dijkstra G,Porte RJ,et al.Smoking behavior in liver transplant recipients[J].Liver Transpl,2009,15(6):648-655.
[36]Jimenez-Romero C,Manrique Municio A,Marques Medina E,et al.Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases[J].Transplant Proc,2006,38(8):2505-2507.
[37]Lee IS,Kim TH,Kim YH,et al.Clinical significance of gastric cancer surveillance in renal transplant recipients[J].World JSurg,2012,36(8):1806-1810.--